291 related articles for article (PubMed ID: 29778259)
1. Five Questions Concerning Managing Hepatitis C in the Justice System: Finding Practical Solutions for Hepatitis C Virus Elimination.
Spaulding AC; Adee MG; Lawrence RT; Chhatwal J; von Oehsen W
Infect Dis Clin North Am; 2018 Jun; 32(2):323-345. PubMed ID: 29778259
[TBL] [Abstract][Full Text] [Related]
2. Elimination of Hepatitis C Virus in Australia: Laying the Foundation.
Dore GJ; Hajarizadeh B
Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255
[TBL] [Abstract][Full Text] [Related]
3. Funding Hepatitis C Treatment in Correctional Facilities by Using a Nominal Pricing Mechanism.
Spaulding AC; Chhatwal J; Adee MG; Lawrence RT; Beckwith CG; von Oehsen W
J Correct Health Care; 2019 Jan; 25(1):15-24. PubMed ID: 30322323
[TBL] [Abstract][Full Text] [Related]
4. Localized US Efforts to Eliminate Hepatitis C.
Gaudino A; Gay B; Garmon C; Selick M; Vreeland R; Burk K; Huriaux E; Facente SN; Luetkemeyer A; Waters P; Graham CS
Infect Dis Clin North Am; 2018 Jun; 32(2):293-311. PubMed ID: 29778257
[TBL] [Abstract][Full Text] [Related]
5. Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
He T; Li K; Roberts MS; Spaulding AC; Ayer T; Grefenstette JJ; Chhatwal J
Ann Intern Med; 2016 Jan; 164(2):84-92. PubMed ID: 26595252
[TBL] [Abstract][Full Text] [Related]
6. Opportunities to address the hepatitis C epidemic in the correctional setting.
Boutwell AE; Allen SA; Rich JD
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S367-72. PubMed ID: 15768350
[TBL] [Abstract][Full Text] [Related]
7. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective.
Jonas MC; Loftus B; Horberg MA
Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C Virus Diagnosis and the Holy Grail.
Applegate TL; Fajardo E; Sacks JA
Infect Dis Clin North Am; 2018 Jun; 32(2):425-445. PubMed ID: 29778264
[TBL] [Abstract][Full Text] [Related]
9. Consensus recommendations on the management of hepatitis C in Australia's prisons.
Winter RJ; Sheehan Y; Papaluca T; Macdonald GA; Rowland J; Colman A; Stoove M; Lloyd AR; Thompson AJ
Med J Aust; 2023 Mar; 218(5):231-237. PubMed ID: 36871200
[TBL] [Abstract][Full Text] [Related]
10. Advancing Hepatitis C Elimination through Opt-Out Universal Screening and Treatment in Carceral Settings, United States.
McNamara M; Furukawa N; Cartwright EJ
Emerg Infect Dis; 2024 Apr; 30(13):S80-S87. PubMed ID: 38561831
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals.
Gountas I; Sypsa V; Papatheodoridis G; Souliotis K; Athanasakis K; Razavi H; Hatzakis A
World J Gastroenterol; 2019 Mar; 25(11):1327-1340. PubMed ID: 30918426
[TBL] [Abstract][Full Text] [Related]
12. Tailored screening and dedicated funding for direct acting antiviral drugs: how to keep Italy on the road to hepatitis C virus elimination?
Kondili LA; Blach S; Razavi H; Craxì A
Ann Ist Super Sanita; 2020; 56(3):325-329. PubMed ID: 32959798
[TBL] [Abstract][Full Text] [Related]
13. Addressing Hepatitis C in the American Incarcerated Population: Strategies for Nationwide Elimination.
Ocal S; Muir AJ
Curr HIV/AIDS Rep; 2020 Feb; 17(1):18-25. PubMed ID: 31933274
[TBL] [Abstract][Full Text] [Related]
14. Can hepatitis C be eradicated in the United States?
Edlin BR; Winkelstein ER
Antiviral Res; 2014 Oct; 110():79-93. PubMed ID: 25110202
[TBL] [Abstract][Full Text] [Related]
15. Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs.
Martinello M; Dore GJ; Matthews GV; Grebely J
Infect Dis Clin North Am; 2018 Jun; 32(2):371-393. PubMed ID: 29778261
[TBL] [Abstract][Full Text] [Related]
16. Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons who inject drugs.
Sulkowski MS; Martinez A; Tyson GL; Scholz K; Franco RA; Kohli A; Julius SF; Deming P; Fink SA; Lynch K; Roytman M; Stainbrook TR; Turner MD; Viera-Briggs M; Ramers CB
J Viral Hepat; 2024 Jun; 31(6):342-356. PubMed ID: 38433561
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons: A Systematic Review.
Seval N; Wurcel A; Gunderson CG; Grimshaw A; Springer SA
Infect Dis Clin North Am; 2020 Sep; 34(3):559-584. PubMed ID: 32782102
[TBL] [Abstract][Full Text] [Related]
18. Impact of 5 years of hepatitis C testing and treatment in the North East of England prisons.
Johnson A; Shearer J; Thompson C; Jelley R; Aldridge J; Allsop C; Kerry J; Jones D; McCullough F; Miller C; Valappil M; Taha Y; Masson S; Jefferson T; Lawton C; Christensen L; McPherson S
J Viral Hepat; 2023 Dec; 30(12):914-921. PubMed ID: 37700492
[TBL] [Abstract][Full Text] [Related]
19. Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C).
Rance J; Lafferty L; Treloar C;
Harm Reduct J; 2021 Apr; 18(1):46. PubMed ID: 33902595
[TBL] [Abstract][Full Text] [Related]
20. HIV and HCV in U.S. Prisons and Jails: The Correctional Facility as a Bellwether Over Time for the Community's Infections.
Spaulding AC; Anderson EJ; Khan MA; Taborda-Vidarte CA; Phillips JA
AIDS Rev; 2017; 19(3):134-147. PubMed ID: 28926560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
